3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
17
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
1
Thyroid Carcinoma, Anaplastic
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Non Small Cell Lung Cancer
1
Liver Cirrhosis
1
Hematologic Neoplasms
1
HIV Infected Patients With Cancer Treated by ICPi
1
Glioma
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
tislelizumab
4
Sorafenib
3
Propranolol
3
ledipasvir
2
entecavir
2
donafenib
2
apatinib
2
Sofosbuvir
2
Ribavirin
2
Radiotherapy
2
Proton Therapy
2
Bevacizumab
2
sitravatinib
1
polysaccharide MGN3
1
palbociclib
1
lenvatinib
1
lens intermediate filament proteins
1
ledipasvir, sofosbuvir drug combination
1
envafolimab
1
elbasvir-grazoprevir drug combination
1
daclatasvir
1
camrelizumab
1
atezolizumab
1
anlotinib
1
Vitamin D
1
Urination
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
Simeprevir
1
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Carcinoma, Hepatocellular
×
Blood Specimen Collection
×
Clear all
NCT07119957
2025-08-13
ProspEXPO
University Hospital, Angers
Phase NA
Not yet recruiting
300 enrolled